Hekabio K.K.

Hekabio K.K. company information, Employees & Contact Information

Explore related pages

Hekabio K.K. email format Hekabio K.K. management contacts

Related company profiles:

HekaBio's mission is to accelerate patient access to world-leading healthcare solutions throughout Asia Pacific, starting with Japan. We are a healthcare asset in-licensing, development and commercialization platform, advancing a portfolio of breakthrough therapeutic innovations.

Company Details

Employees
16
Founded
-
Address
1-9-15 Nihonbashimuromachi, Chikiriya Tokyo Bldg 8f,japan
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
hekabio.com
Keywords
Oncology, Clinical development, Regulatory development, Commercialization, Medical Device, Reimbursement, Pharmaceuticals, Business Development, Bioventure, Cardiology, CNS, Ophthalmology, BD&L, Pharmaceutical In-Licensing, Medical Device In-Licensing.
HQ
Chuo-ku, Tokyo
Competitors
Candel Therapeutics, Nozomi MedAlliance K.K., Precision BioSciences, Inc., Solid Biosciences, JCR Pharmaceuticals, Serpin Pharma, Lyell Immunopharma, NKGen Biotech, Inc., Alexion Pharmaceuticals, Inc., HOPE International Development Agency, Japan.
Looking for a particular Hekabio K.K. employee's phone or email?

Hekabio K.k. Questions

News

NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan - GlobeNewswire

NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan GlobeNewswire

HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation - Business Wire

HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation Business Wire

NKGen Biotech and HekaBio enter strategic partnership to bring novel NK cell therapy to Japan - BioSpectrum Asia

NKGen Biotech and HekaBio enter strategic partnership to bring novel NK cell therapy to Japan BioSpectrum Asia

Revolutionary NK Cell Therapy Targets Alzheimer's: NKGen Secures Fast-Track Access to Japanese Market - Stock Titan

Revolutionary NK Cell Therapy Targets Alzheimer's: NKGen Secures Fast-Track Access to Japanese Market Stock Titan

Oncology Company Alpha Tau Raises $29 Million - CTech

Oncology Company Alpha Tau Raises $29 Million CTech

Strategies for Medtech and Biotech Businesses to Win Japan's Healthcare Market - Asia Business Outlook

Strategies for Medtech and Biotech Businesses to Win Japan's Healthcare Market Asia Business Outlook

Companies like Hekabio K.K.

Solid Biosciences logo - Similar company to Hekabio K.K.

Solid Biosciences

135
HOPE International Development Agency, Japan logo - Similar company to Hekabio K.K.

Hope International D...

19
Alexion Pharmaceuticals, Inc. logo - Similar company to Hekabio K.K.

Alexion Pharmaceutic...

5.06K
JCR Pharmaceuticals logo - Similar company to Hekabio K.K.

Jcr Pharmaceuticals

124
Precision BioSciences, Inc. logo - Similar company to Hekabio K.K.

Precision Bioscience...

119
Candel Therapeutics logo - Similar company to Hekabio K.K.

Candel Therapeutics

69
Lyell Immunopharma logo - Similar company to Hekabio K.K.

Lyell Immunopharma

253
Serpin Pharma logo - Similar company to Hekabio K.K.

Serpin Pharma

8
NKGen Biotech, Inc. logo - Similar company to Hekabio K.K.

Nkgen Biotech, Inc.

58
Nozomi MedAlliance K.K. logo - Similar company to Hekabio K.K.

Nozomi Medalliance K.K.

5

Top Hekabio K.K. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant